Document Detail

Fetal cardiac screening and variation in prenatal detection rates of congenital heart disease: why bother with screening at all?
MedLine Citation:
PMID:  22413979     Owner:  NLM     Status:  In-Data-Review    
Antenatal screening for fetal cardiac abnormalities was introduced over 25 years ago, yet detection of congenital heart disease before birth remains a challenge. While experienced tertiary centers report a high level of diagnostic accuracy, with most major forms of congenital heart disease being detectable before birth, the overall detection rate remains low. Pregnancies at increased risk of having an affected baby are referred to tertiary centers for fetal ECG, but most cases of congenital heart disease will occur in low-risk pregnancies. These cases will only be detected by screening the low-risk population at the time of routine obstetric scanning. Many obstetric ultrasound units have learnt to successfully obtain, and correctly interpret, views of the heart, including the four-chamber view and outflow tract views. However, standards for doing this are not uniform, nationally or internationally, so there is a significant variation in detection rates across individual countries and between different countries. Early diagnosis of babies with lesions that can result in cardiovascular collapse and death, could improve their survival as well as reducing morbidity. In addition, detection of a cardiac abnormality during pregnancy allows time to prepare parents for the likely course of events after birth. It also facilitates detection of other abnormalities in the baby and gives parents a choice, even if the choice is difficult and unwelcome. As well as providing parents with accurate and up-to-date information regarding the their baby's abnormality, it is vital to provide continuing support to help them deal with the problem, regardless of what decisions they make. Much work remains to establish a uniform standard for antenatal detection of cardiac abnormalities. More recent national guidelines for examining the fetal heart along with formalized auditing processes should help to achieve this, although considerable time and effort will be required, particularly with regard to the teaching and training required.
Gurleen Sharland
Related Documents :
2437799 - Declining serum concentrations of the beta-subunit of human chorionic gonadotropin and ...
8567799 - Identification of hormonal parameters for successful systemic single-dose methotrexate ...
6462569 - Human chorionic gonadotropin in maternal plasma after induced abortion, spontaneous abo...
15032969 - Screening for down's syndrome in early and late first and second trimester using six ma...
7509759 - Diagnosis of intrauterine and ectopic pregnancy at 5-7 postmenstrual weeks.
7646609 - Human chorionic gonadotropin supplementation in recurring pregnancy loss: a controlled ...
3384979 - Screening of antenatal patients in a multiethnic community for beta thalassaemia trait.
21655339 - High-response intrauterine insemination cycles converted to low-cost in vitro fertiliza...
22813369 - Pregnancy after cardiac transplantation.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Future cardiology     Volume:  8     ISSN:  1744-8298     ISO Abbreviation:  Future Cardiol     Publication Date:  2012 Mar 
Date Detail:
Created Date:  2012-03-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101239345     Medline TA:  Future Cardiol     Country:  England    
Other Details:
Languages:  eng     Pagination:  189-202     Citation Subset:  IM    
Fetal Cardiology Unit, Evelina Children's Hospital, Westminster Bridge Road, London SE1 7EH, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Neurological injury and anesthetic neurotoxicity following neonatal cardiac surgery: does the head r...
Next Document:  Future horizons for catheter-based interventions in adult congenital and structural heart disease.